Vitality Watch

Dossier pubmed preclinical 01-oct-2026
Animal model, organoid, or cell-culture result — not yet human

Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images.

Key claim: ChromAgeNet, a deep-learning model trained on 3D DAPI-stained nuclei, discriminates young from aged murine hematopoietic stem cells from chromatin spatial features (AUROC 0.77) and can be used to screen epigenetic drugs for HSC rejuvenation phenotypes.

Abstract

The functional decline of the hematopoietic system during aging affects organismal function and contributes to reduced healthspan. Quantifying hematopoietic aging holds great scientific and clinical relevance. Alterations in chromatin architecture are a well-established hallmark of aging that encode rich and informative signatures of the aging process, yet they remain largely unexplored as quantitative markers. Here, we present an interpretable deep learning approach based on convolutional neural networks, ChromAgeNet, that learns changes in the spatial features of chromatin architecture upon aging of hematopoietic stem cells (HSCs). We trained our algorithm on 3D microscope images of DAPI-stained HSC nuclei to discriminate between young and aged murine HSCs, achieving an AUROC of 0.77 ± 0.03. This approach outperforms classical machine learning models trained on handcrafted chromatin features from the same dataset. We then applied explainable artificial intelligence techniques, identifying chromatin entropy, peripheral heterochromatin, and chromatin condensates as predictive markers. As a proof of concept, we evaluated the potential of our model as a phenotypic screening tool for aged HSCs treated with epigenetic drugs to detect rejuvenation. Altogether, we demonstrate that changes in chromatin organization can be modeled via machine learning to predict age-associated chromatin states in the hematopoietic compartment. Our developed framework, ChromAgeNet, serves as an interpretable algorithm to unravel the intricate relationship between chromatin changes and stem cell aging, and advance high-throughput drug screening for rejuvenation therapies.

Why this matters

Most aging biomarkers in HSCs are molecular (methylation, transcriptomic, proteomic clocks); ChromAgeNet shows that a cheap, stain-based morphological readout of 3D nuclear chromatin carries age signal at single-cell resolution and can be wired directly into drug screening. The interpretability callouts — chromatin entropy, peripheral heterochromatin loss, condensate changes — pin the aged phenotype to specific nuclear-architecture features that intersect heterochromatin-derepression and epigenetic-drift narratives. It is a measurement advance on an established hallmark, still murine, and the human-translation path (do human HSC nuclei behave the same, and does the classifier transfer?) is open.

Source

Link

Briefing card

Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images.
Stage: preclinical · pubmed · 01-oct-2026

Applies to preclinical researchers screening epigenetic compounds in murine hematopoietic stem cells; no human readout is available from this work.

ChromAgeNet, a deep-learning model trained on 3D DAPI-stained nuclei, discriminates young from aged murine hematopoietic stem cells from chromatin spatial features (AUROC 0.77) and can be used to screen epigenetic drugs for HSC rejuvenation phenotypes.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1111/acel.70656

build build 880 · 2bcef25 · 2026-11-18